Haemorrhage: Types, Causes, Symptoms, Treatment — A Clinical Overview

gkloka
0

 

Medical banner showing haemorrhage types, causes, symptoms and treatment with doctor and patients illustration

Overview: A haemorrhage denotes bleeding from damaged blood vessels. It may be external and readily apparent, or internal and concealed. The impact ranges from minor, self-limited bruising to rapidly fatal blood loss. This guide summarises types, pathophysiology, clinical presentation, diagnostic approaches, acute management, definitive treatments, complications, risk stratification and prognosis. The aim is to present clear, actionable clinical information for clinicians, students and informed patients.


Table of contents

  1. What is a haemorrhage?
  2. Classification by location and mechanism
  3. Internal versus external haemorrhage — clinical implications
  4. Common anatomical sites and clinical presentations
  5. Causes and pathophysiological mechanisms
  6. Clinical features and red flags
  7. Diagnostic approach and investigations
  8. Acute management — first response and stabilisation
  9. Definitive treatment modalities
  10. Complications and risk factors
  11. Prognosis and follow-up considerations
  12. Prevention and patient education
  13. Frequently asked questions (FAQs)
  14. References (titles only — no links)

1. What is a haemorrhage?

haemorrhage is the escape of blood from the vascular compartment due to disruption of vessel integrity. It may occur in the external environment (through a wound or orifice) or within body cavities and organs (internal haemorrhage). Clinically, haemorrhage is significant when it results in hemodynamic instability, impaired tissue perfusion, or organ dysfunction.

Key point: Hemodynamic impact, not just visible blood loss, determines clinical urgency. Even occult internal bleeding can be life-threatening.


2. Classification by location and mechanism

Haemorrhages are most usefully categorised by locationanatomical compartment, and mechanism.

By compartment:

  • External haemorrhage — blood exits the body (e.g., lacerations, epistaxis).
  • Internal haemorrhage — blood accumulates within tissues or body cavities (e.g., intracranial, intra-abdominal, intrathoracic).

By vessel type/mechanism:

  • Arterial bleeding — high-pressure, pulsatile blood loss; rapid volume depletion.
  • Venous bleeding — lower pressure, may be profuse if large veins affected.
  • Capillary/venule bleeding — oozing, often slower.
  • Bleeding into tissue — contusions and haematomas.

Special categories:

  • Postpartum haemorrhage (PPH) — obstetric emergency after delivery.
  • Subarachnoid haemorrhage (SAH) — bleeding into the subarachnoid space, frequently due to aneurysm rupture.
  • Intracerebral haemorrhage — bleeding within the brain parenchyma.
  • Haemothorax — blood in the pleural space.
  • Gastrointestinal haemorrhage — upper or lower GI bleeding.

Key point: Identifying the compartment and source guides immediate management.


3. Internal versus external haemorrhage — clinical implications

External haemorrhage is usually visible and amenable to immediate first-aid measures (direct pressure, elevation, haemostatic dressings). Internal haemorrhage can be deceptive — the external appearance may be minimal or absent, while the internal blood loss can be large.

Clinical implications:

  • External bleeding allows visual assessment but may still cause massive blood loss.
  • Internal bleeding requires high clinical vigilance and often imaging; signs are frequently non-specific (e.g., hypotension, confusion, abdominal pain, back pain, dyspnoea).

Key point: Always consider internal bleeding when unexplained haemodynamic compromise occurs after trauma, surgery, or spontaneously in patients on anticoagulants.


4. Common anatomical sites and clinical presentations

Head and brain

  • Intracerebral haemorrhage (ICH): focal neurological deficit, reduced level of consciousness, headache, vomiting, hypertension history.
  • Subarachnoid haemorrhage (SAH): sudden severe "thunderclap" headache, neck stiffness, photophobia, meningism, possible loss of consciousness.

Thorax

  • Haemothorax: pleuritic chest pain, respiratory distress, reduced breath sounds, dullness to percussion; may progress to tension physiology.
  • Pulmonary hemorrhage: haemoptysis, hypoxia.

Abdomen and retroperitoneum

  • Intra-abdominal bleeding (e.g., splenic rupture): abdominal pain, distension, peritonism, referred shoulder pain (Kehr’s sign), hypotension.
  • Retroperitoneal haemorrhage: flank/back pain, sometimes minimal abdominal signs; common with anticoagulation.

Gastrointestinal tract

  • Upper GI bleeding (oesophagus, stomach, duodenum): haematemesis, melena.
  • Lower GI bleeding (colon, rectum, small bowel): bright red blood per rectum, haematochezia.

Genital/obstetric

  • Postpartum haemorrhage (PPH): heavy vaginal bleeding after delivery; uterine atony is the most common cause.

Limbs and soft tissues

  • Haematoma and compartment syndrome: swelling, pain, tense compartments, neurovascular compromise.

Eyes

  • Subconjunctival haemorrhage: visible red patch on sclera; usually benign and self-limited.

Key point: Presentation varies with location; correlate symptoms with likely compartments and risk factors (trauma, anticoagulation, aneurysm, obstetric history).


5. Causes and pathophysiological mechanisms

Trauma

  • Blunt or penetrating injury disrupts vessels.
  • Iatrogenic causes: surgical bleeding, invasive procedures, vascular access complications.

Vascular lesions

  • Aneurysm rupture (e.g., intracranial saccular aneurysm — SAH).
  • Arteriovenous malformations (AVMs).
  • Atherosclerotic vessel disruption.

Coagulopathy and haemostatic defects

  • Congenital (e.g., haemophilia, von Willebrand disease).
  • Acquired: liver disease, disseminated intravascular coagulation (DIC), thrombocytopenia.
  • Anticoagulant and antiplatelet medications (warfarin, direct oral anticoagulants, aspirin, clopidogrel).

Medical conditions

  • Hypertension (risk factor for intracerebral haemorrhage).
  • Malignancy invading vessels.
  • Vascular inflammation (vasculitis).

Infective causes

  • Viral haemorrhagic fevers (rare in many settings but significant in endemic regions).
  • Sepsis-associated coagulopathy.

Obstetric causes

  • Uterine atony, retained placenta, genital tract lacerations, uterine rupture.

Key point: Treatment requires addressing both the bleeding source and predisposing haemostatic abnormalities.


6. Clinical features and red flags

Local signs

  • External bleeding, expanding haematoma, visible wound.

Systemic signs of significant blood loss

  • Tachycardia, hypotension, pallor, cold clammy skin, oliguria, altered mental status (from hypoperfusion).

Red flags indicating life-threatening haemorrhage

  • Systolic blood pressure <90 mmHg or signs of shock.
  • Rapidly expanding neck or facial haematoma risking airway compromise.
  • Neurological deterioration (suggesting intracranial haemorrhage).
  • Massive haemoptysis or haematemesis.
  • Postpartum bleeding >500 mL (vaginal delivery) or >1000 mL (caesarean) with ongoing blood loss.

Key point: Rapid assessment and triage using ABC principles (Airway, Breathing, Circulation) are essential.


7. Diagnostic approach and investigations

Immediate bedside evaluation

  • Airway assessment (risk of airway compromise, particularly with facial/neck bleeding).
  • Breathing and oxygenation — respiratory rate, oxygen saturation, signs of haemothorax or pulmonary haemorrhage.
  • Circulatory status — heart rate, blood pressure, capillary refill, peripheral perfusion.
  • Focused history — onset, mechanism (trauma, recent procedures), medications (anticoagulants), obstetric status.
  • Focused physical examination — wound inspection, abdominal palpation, neurological exam.

Essential investigations

  • Blood tests: full blood count (haemoglobin, platelets), coagulation screen (INR, aPTT), blood type and crossmatch, electrolytes, lactate, liver function tests.
  • Point-of-care ultrasound (FAST/extended-FAST): rapid assessment for intraperitoneal or pericardial fluid in trauma.
  • Chest X-ray: suspected haemothorax, pulmonary pathology.
  • CT imaging: CT brain for suspected intracranial haemorrhage; CT angiography for vascular sources; CT abdomen/pelvis for intra-abdominal bleeding.
  • Endoscopy: upper GI endoscopy for suspected upper gastrointestinal bleeding.
  • Angiography: diagnostic with potential for therapeutic embolisation (interventional radiology).

Key point: Imaging choice is guided by clinical stability — unstable patients require immediate resuscitation; imaging is deferred until the patient is stabilised or if it will change immediate management.


8. Acute management — first response and stabilisation

Pre-hospital and immediate measures

  • Call for emergency help and transfer to an appropriate acute facility.
  • Control external bleeding: apply firm direct pressure with gauze or dressings; do not remove impaled objects—stabilise them.
  • Tourniquet use: apply a tourniquet for severe limb bleeding when direct pressure fails — record application time.
  • Airway protection: prepare for airway management if compromised.
  • High-flow oxygen and continuous monitoring.
  • IV access: two large-bore peripheral cannulae (or central venous access if necessary).
  • Fluid resuscitation: balanced crystalloids; avoid excessive crystalloid that may dilute clotting factors.
  • Blood transfusion: follow massive transfusion protocols if required (balanced ratio of red cells, plasma, platelets).
  • Reverse anticoagulation: when indicated (e.g., vitamin K and prothrombin complex concentrate for warfarin; specific reversal agents for DOACs where appropriate).
  • Analgesia and sedation as required, with caution to avoid masking neurological changes.

Resuscitation principles

  • Follow Advanced Trauma Life Support (ATLS) or equivalent protocols.
  • Permissive hypotension may be considered in uncontrolled haemorrhage until haemorrhage control is achieved (except in traumatic brain injury where adequate cerebral perfusion is required).
  • Massive transfusion protocols (MTP): activate early for anticipated large blood loss.

Key point: Early haemorrhage control and correction of coagulopathy save lives; anticipate the need for blood and reversal agents.


9. Definitive treatment modalities

Local haemostatic measures

  • Suturing, vessel ligation, topical haemostatic agents.
  • Haemostatic dressings and packing for cavities (e.g., nasal packing, pelvic packing).

Endovascular therapy

  • Angiographic embolisation: effective for pelvic fractures, solid organ injuries (liver, kidney, spleen), and some GI bleeds.
  • Minimally invasive and organ-sparing in many cases.

Surgical intervention

  • Laparotomy/thoracotomy/craniotomy for uncontrolled internal bleeding or presence of injuries requiring operative repair.
  • Indications include peritonitis, expanding haematoma with compartment syndrome, refractory haemodynamic instability.

Neurosurgical measures

  • Decompressive craniectomy, evacuation of intracerebral haematoma for selected patients.
  • Management of subarachnoid haemorrhage: securing ruptured aneurysms by endovascular coiling or surgical clipping.

Obstetric care

  • Uterotonic agents (oxytocin, ergometrine where appropriate) for uterine atony.
  • Surgical interventions: uterine balloon tamponade, uterine artery embolisation, uterine compression sutures, hysterectomy as a life-saving measure.

Pharmacological

  • Antifibrinolytics: tranexamic acid (TXA) has established benefit in trauma and postpartum haemorrhage when given early.
  • Replacement therapy: blood components, cryoprecipitate, factor concentrates as indicated.
  • Reversal agents: vitamin K, prothrombin complex concentrates, idarucizumab for dabigatran, andexanet alfa for factor Xa inhibitors (where available and indicated).

Key point: Choice of definitive therapy depends on site, cause, haemodynamic status, and available expertise and resources.


10. Complications and risk factors

Immediate complications

  • Hypovolaemic shock and multi-organ failure.
  • Rebleeding after initial control.
  • Airway compromise (particularly cervicofacial haematomas).

Early and late complications

  • Infection in haematomas or surgical sites.
  • Ischaemic injury following prolonged hypotension.
  • Neurological deficits after intracranial haemorrhage.
  • Compartment syndrome with soft-tissue bleeding.
  • Thromboembolic events in immobilised patients.
  • Chronic anaemia and need for prolonged transfusion or iron therapy.

Risk factors for poor outcome

  • Advanced age, comorbid cardiovascular disease, uncontrolled hypertension, anticoagulant therapy, delayed presentation, massive blood loss, and multi-system trauma.

Key point: Risk mitigation includes early control, correction of coagulopathy, appropriate prophylaxis for venous thromboembolism when safe, and vigilant monitoring.


11. Prognosis and follow-up considerations

Prognosis varies widely. Mortality and morbidity depend on:

  • Anatomical site (intracranial and major thoracic haemorrhages carry higher risk).
  • Volume and rate of blood loss.
  • Time to definitive control.
  • Patient comorbidities and baseline functional status.

Follow-up care includes:

  • Monitoring haemoglobin, renal function, and coagulation parameters.
  • Rehabilitation for neurological or functional deficits.
  • Review and adjustment of anticoagulation therapy balancing thrombosis versus bleeding risk.
  • Investigation for underlying causes (e.g., aneurysm screening in non-traumatic SAH, coagulation workup).

Key point: Early multidisciplinary involvement (surgery, interventional radiology, haematology, critical care, rehabilitation) optimises outcomes.


12. Prevention and patient education

Primary prevention

  • Control cardiovascular risk factors (e.g., blood pressure management to reduce risk of intracerebral haemorrhage).
  • Safe prescribing and regular review of anticoagulant/antiplatelet therapy; educate patients on bleeding risks and signs.

Secondary prevention

  • Address reversible causes (e.g., aneurysm repair, correcting coagulopathy).
  • Vaccination and safe practices where infectious haemorrhagic diseases are a concern.

Patient education

  • Recognise red flags: sudden severe headache, unexplained dizziness or weakness, tachycardia, persistent bleeding, syncope.
  • For patients on anticoagulants: carry information about medication and reversal agents; seek prompt evaluation for any significant bleed.

Key point: Informed patients and cautious management of bleeding risks reduce harm.


13. Frequently asked questions (FAQs)

Q: Why can a haemorrhage be fatal?
A: Severe haemorrhage leads to loss of circulating volume causing hypovolaemic shock, inadequate tissue perfusion, multi-organ failure and death if not rapidly corrected.

Q: How can internal bleeding be detected early?
A: Early detection relies on clinical suspicion: unexplained hypotension, tachycardia, falling haemoglobin, abdominal distension or neurological changes should prompt urgent imaging and investigation.

Q: How do you control external haemorrhage at the scene?
A: Apply firm direct pressure, maintain pressure until bleeding stops, use a tourniquet for uncontrollable limb bleeding if trained to do so, and seek emergency care.

Q: Can people on anticoagulants survive internal bleeding?
A: Many can if recognised early and managed promptly; reversal of anticoagulation, targeted interventions and supportive care are often effective.

Q: When should tranexamic acid be given?
A: TXA is indicated early in trauma with significant bleeding and in postpartum haemorrhage within recommended time windows as part of established protocols.


14. References

  • “Management of Major Haemorrhage: A Practical Guide”
  • “Trauma Resuscitation and Haemorrhage Control”
  • “Clinical Guidelines for the Management of Intracranial Haemorrhage”
  • “Postpartum Haemorrhage: Emergency Management and Protocols”
  • “Tranexamic Acid in Trauma and Obstetric Haemorrhage: Evidence and Guidelines”
  • “Surgical and Endovascular Techniques for Haemorrhage Control”
  • “Haemostatic Disorders and Anticoagulation Reversal: Clinical Practice”

Closing summary

Haemorrhage is a heterogeneous clinical problem that ranges from trivial to life-threatening. Rapid recognition, targeted resuscitation, correction of haemostatic abnormalities and definitive control of the bleeding source are the pillars of effective management. A multidisciplinary approach and close attention to risk factors and prevention strategies improve patient outcomes. If there is any concern about active or suspected bleeding, immediate medical evaluation is essential.


Disclaimer: This article provides general clinical information about haemorrhage for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. If you suspect a severe bleed or haemorrhage, seek immediate emergency medical attention. Always follow the guidance of qualified healthcare professionals for personal medical care.

Post a Comment

0 Comments

Post a Comment (0)

#buttons=(Ok, Go it!) #days=(20)

Our website uses cookies to enhance your experience. Check Now
Ok, Go it!